Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer
Ragnarsson, O.; Piasecka, M.; Hallqvist, A. Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer. Curr. Oncol. 2022, 29, 3494-3498. https://doi.org/10.3390/curroncol29050282
Ragnarsson O, Piasecka M, Hallqvist A. Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer. Current Oncology. 2022; 29(5):3494-3498. https://doi.org/10.3390/curroncol29050282
Chicago/Turabian StyleRagnarsson, Oskar, Marta Piasecka, and Andreas Hallqvist. 2022. "Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer" Current Oncology 29, no. 5: 3494-3498. https://doi.org/10.3390/curroncol29050282